Citrine Capital’s Broadcom AVGO Stock Holding History

Citrine Capital’s Portfolio AVGO Stock Details AVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$820K	Buy	2,170 +110	+5%	+$44.1K	0.3%	23
2026 Q1	$638K	Buy	+2,060	New	+$678K	0.28%	27

Other funds holding AVGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Citrine Capital's AVGO Position: Q2 2026 in Review

Citrine Capital increased its Broadcom (AVGO) stake by 5.3% in Q2 2026, buying an estimated $44.1K and bringing the position to 2,170 shares worth $820K. The position accounts for 0.3% of the portfolio, ranked #23.

Citrine Capital first reported a position in AVGO in Q1 2026 and has held it in 2 quarters since. 4,802 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

Citrine Capital held 2,170 shares of Broadcom worth $820K as of Q2 2026.
Citrine Capital bought 110 Broadcom shares in Q2 2026, an estimated $44.1K.
Broadcom made up 0.3% of Citrine Capital's portfolio in Q2 2026, its #23 holding.
Citrine Capital first reported a position in Broadcom in Q1 2026 and has held it in 2 quarters since.
4,802 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Citrine Capital's 13F filing for Q2 2026, filed 23 Jul 2026.